Literature DB >> 7564270

High glucose alters actin assembly in glomerular mesangial and epithelial cells.

X Zhou1, R D Hurst, D Templeton, C I Whiteside.   

Abstract

BACKGROUND: Glomerular mesangial and epithelial cell structure and function are maintained by cytoskeletal protein organization and function. To determine whether the diabetic milieu alters filamentous (F-) actin assembly, the spatial distributions and content of F- and monomeric (G-) actin were analyzed in rat mesangial and glomerular epithelial cells (10 to 15 passages) cultured for 5 days in high (22.4 mM) or normal (5.2 mM) glucose and in cells of whole glomeruli isolated from streptozotocin-treated diabetic or normal rats. EXPERIMENTAL
DESIGN: Cells were labeled with the fluorescent probes rhodamine-phalloidin and FITC-DNase-1 specific for F- and G-actin, respectively. The average pixel intensities per cell were measured using dual channel confocal laser scanning microscopy (N = 60 cells per group). Total and G-actin were measured in mesangial cells by a spectrophotometric-based DNase-1 inhibition assay.
RESULTS: In response to endothelin-1, 0.1 microM, vasopressin 1.0 microM, or angiotensin II 1.0 microM, mesangial cells cultured in normal glucose displayed partial disassembly of F-actin characterized by decreased fluorescence intensity (microfilament bundle pattern changed to network) with no change in G-actin fluorescence. In high glucose, but not mannitol (22.4 mM), partial disassembly of F-actin and loss of response to the agonists were observed. In high glucose, the F-actin content (micrograms/mg cellular protein) was reduced significantly with no change in absolute G-actin compared with normal glucose exposure. The effect of high glucose on mesangial cell actin was reversed by returning the cells to normal glucose for 2 days, stimulation with insulin 2 micrograms/ml, or with a protein kinase C inhibitor. Mesangial cells in high glucose were smaller in planar area and exhibited loss of contractile response to endothelin-1 (0.1 microM) or vasopressin (1.0 microM) measured by videomicroscopy. High glucose-induced F-actin disassembly, possibly due to activated protein kinase C, could account for smaller cell size and lack of response to vasopressor agents. Glomerular epithelial cells cultured in normal glucose demonstrated F-actin disassembly and increased G-actin fluorescence intensity in response to A23187 (5 microM) or bradykinin (10 nM). When cultured in high glucose, but not mannitol, increased epithelial G-actin fluorescence and loss of F- and G-actin response to agonists were observed. Although stimulation with insulin reversed the high glucose effect on epithelial G-actin, F-actin remained unresponsive to agonists. The cells of glomeruli isolated from the diabetic rat displayed the same increase in G-actin, no change in F-actin fluorescence, and loss of response to agonist stimulation as observed in cultured epithelial cells.
CONCLUSIONS: These findings suggest that high glucose alters actin assembly in both glomerular mesangial and epithelial cells in vitro and in vivo, possibly contributing to cellular dysfunction in early diabetes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7564270

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  15 in total

1.  O-GlcNAcylation and phosphorylation of β-actin Ser199 in diabetic nephropathy.

Authors:  Yoshihiro Akimoto; Kunimasa Yan; Yuri Miura; Hiroki Tsumoto; Tosifusa Toda; Toshiyuki Fukutomi; Daisuke Sugahara; Akihiko Kudo; Tomio Arai; Yuko Chiba; Shinya Kaname; Gerald W Hart; Tamao Endo; Hayato Kawakami
Journal:  Am J Physiol Renal Physiol       Date:  2019-09-30

2.  Direct interaction between caldesmon and cortactin.

Authors:  Renjian Huang; Gong-Jie Cao; Hongqiu Guo; Jolanta Kordowska; C-L Albert Wang
Journal:  Arch Biochem Biophys       Date:  2006-08-23       Impact factor: 4.013

3.  Evidence coupling increased hexosamine biosynthesis pathway activity to membrane cholesterol toxicity and cortical filamentous actin derangement contributing to cellular insulin resistance.

Authors:  Padma Bhonagiri; Guruprasad R Pattar; Kirk M Habegger; Alicia M McCarthy; Lixuan Tackett; Jeffrey S Elmendorf
Journal:  Endocrinology       Date:  2011-06-28       Impact factor: 4.736

Review 4.  Endothelin and the glomerulus in chronic kidney disease.

Authors:  Matthias Barton; Andrey Sorokin
Journal:  Semin Nephrol       Date:  2015-03       Impact factor: 5.299

Review 5.  Signaling, cytoskeletal and membrane mechanisms regulating GLUT4 exocytosis.

Authors:  Nolan J Hoffman; Jeffrey S Elmendorf
Journal:  Trends Endocrinol Metab       Date:  2011-01-07       Impact factor: 12.015

Review 6.  Endothelin Receptor Antagonists: New Hope for Renal Protection?

Authors:  Sheldon Tobe; Donald E Kohan; Ranjit Singarayer
Journal:  Curr Hypertens Rep       Date:  2015-07       Impact factor: 5.369

7.  Reductions in laminin beta2 mRNA translation are responsible for impaired IGFBP-5-mediated mesangial cell migration in the presence of high glucose.

Authors:  Valerie Schaeffer; Kim M Hansen; David R Morris; Christine K Abrass
Journal:  Am J Physiol Renal Physiol       Date:  2009-10-28

8.  Hexosamine biosynthesis pathway flux contributes to insulin resistance via altering membrane phosphatidylinositol 4,5-bisphosphate and cortical filamentous actin.

Authors:  Padma Bhonagiri; Guruprasad R Pattar; Emily M Horvath; Kirk M Habegger; Alicia M McCarthy; Jeffrey S Elmendorf
Journal:  Endocrinology       Date:  2008-11-26       Impact factor: 4.736

9.  Morphological changes in diabetic kidney are associated with increased O-GlcNAcylation of cytoskeletal proteins including α-actinin 4.

Authors:  Yoshihiro Akimoto; Yuri Miura; Tosifusa Toda; Margreet A Wolfert; Lance Wells; Geert-Jan Boons; Gerald W Hart; Tamao Endo; Hayato Kawakami
Journal:  Clin Proteomics       Date:  2011-09-21       Impact factor: 3.988

10.  Involvement of F-actin in chaperonin-containing t-complex 1 beta regulating mouse mesangial cell functions in a glucose-induction cell model.

Authors:  Jin-Shuen Chen; Li-Chien Chang; Chia-Chao Wu; Lai-King Yeung; Yuh-Feng Lin
Journal:  Exp Diabetes Res       Date:  2011-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.